What is it about?
Management of corticosteroid hypersensitivity is not easy, and the choice of an alternative CS is difcult,owing to the high frequency of cross-reactions. Deflazacort has been reported to be a safe alternative in subjects with CS hypersensitivity, and reports of deflazacort hypersensitivity are rare. Here, we report a difficult-to-manage case of systemic allergic dermatitis caused by deflazacort.
Featured Image
Why is it important?
Our study highlights the need for a review of CS cross-reaction patterns, because none of the current proposals seems to explain the observed clinical findings.
Read the Original
This page is a summary of: Deflazacort hypersensitivity: a difficult-to-manage case of systemic allergic dermatitis and literature review, Contact Dermatitis, June 2016, Wiley,
DOI: 10.1111/cod.12555.
You can read the full text:
Contributors
The following have contributed to this page